Salem Radio Network News Wednesday, January 26, 2022

Health

J&J says its single dose protects against breakthrough COVID-19 for up to 6 months

(Reuters) -Johnson & Johnson said on Thursday that a real-world study showed its single shot COVID-19 vaccine protects against breakthrough infections and hospitalizations for up to six months.

The study, sponsored by the vaccine developer, was conducted between Jan. 1 and Sept. 7 last year, before the Omicron variant was discovered. It is also yet to be peer-reviewed.

J&J said protection against infection from its single dose vaccine starts to wane only from the fourth month compared to the second month in the case of two-dose vaccines from rivals Pfizer Inc and BioNTech’s as well as Moderna.

No waning of protection was found for ICU admissions for all the three vaccines, J&J said.

The company said the study was carried out by collecting claims and laboratory data covering 168 million people.

(Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur)

Previous
Next

Editorial Cartoons

View More »

Steve Breen
Fri, Jan 21, 2022

X CLOSE